1. Home
  2. TOVX vs BFRI Comparison

TOVX vs BFRI Comparison

Compare TOVX & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Theriva Biologics Inc.

TOVX

Theriva Biologics Inc.

HOLD

Current Price

$0.14

Market Cap

11.1M

Sector

Health Care

ML Signal

HOLD

Logo Biofrontera Inc.

BFRI

Biofrontera Inc.

HOLD

Current Price

$0.66

Market Cap

12.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TOVX
BFRI
Founded
2001
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.1M
12.2M
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
TOVX
BFRI
Price
$0.14
$0.66
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 1.1M
182.1K
Earning Date
11-12-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 89.07
67.70
EPS
★ N/A
N/A
Revenue
N/A
★ $41,705,000.00
Revenue This Year
N/A
$12.70
Revenue Next Year
N/A
$13.40
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 11.75
52 Week Low
$0.14
$0.57
52 Week High
$0.49
$1.66

Technical Indicators

Market Signals
Indicator
TOVX
BFRI
Relative Strength Index (RSI) 30.97 35.83
Support Level $0.14 N/A
Resistance Level $0.25 $0.95
Average True Range (ATR) 0.02 0.09
MACD -0.00 -0.01
Stochastic Oscillator 14.48 28.45

Price Performance

Historical Comparison
TOVX
BFRI

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.

About BFRI Biofrontera Inc.

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.

Share on Social Networks: